 Advisor Group Holdings Inc. raised its position in Charles River Laboratories Intl. Inc NYSE:CRL by 16.1 in the second quarter, according to its most recent Form 13F filing with the Securities Exchange Commission. The fund owned 13,674 shares of the medical research companys stock after acquiring an additional 1,894 shares during the quarter. Advisor ... 